Silicon Laboratories Inc. | |||
Condensed Consolidated Balance Sheets | |||
(In thousands, except per share data) | |||
(Unaudited) | |||
|
| |||
|
| June 29,
|
| December 30,
|
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents | $ 240,834 |
| $ 227,504 |
Short-term investments | 98,336 |
| 211,720 |
Accounts receivable, net | 41,212 |
| 29,295 |
Inventories | 166,079 |
| 194,295 |
Prepaid expenses and other current assets | 53,585 |
| 75,117 |
Total current assets | 600,046 |
| 737,931 |
Property and equipment, net | 139,397 |
| 145,890 |
Goodwill | 376,389 |
| 376,389 |
Other intangible assets, net | 47,374 |
| 59,533 |
Other assets, net | 86,781 |
| 123,313 |
Total assets | $ 1,249,987 |
| $ 1,443,056 |
Liabilities and Stockholders' Equity |
|
|
|
Current liabilities: |
|
|
|
Accounts payable | $ 39,295 |
| $ 57,498 |
Revolving line of credit | — |
| 45,000 |
Deferred revenue and returns liability | 3,323 |
| 2,117 |
Other current liabilities | 57,495 |
| 58,955 |
Total current liabilities | 100,113 |
| 163,570 |
Other non-current liabilities | 56,845 |
| 70,804 |
Total liabilities | 156,958 |
| 234,374 |
Commitments and contingencies |
|
|
|
Stockholders' equity: |
|
|
|
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued | — |
| — |
Common stock – $0.0001 par value; 250,000 shares authorized; 32,289 and 31,897 shares issued and outstanding at June 29, 2024 and December 30, 2023, respectively | 3 |
| 3 |
Additional paid-in capital | 39,232 |
| 16,973 |
| Retained earnings | 1,054,048 |
| 1,192,731 |
| Accumulated other comprehensive loss | (254) |
| (1,025) |
| Total stockholders' equity | 1,093,029 |
| 1,208,682 |
| Total liabilities and stockholders' equity | $ 1,249,987 |
| $ 1,443,056 |
|
Silicon Labs Reports Second Quarter 2024 Results
|
|
||||||
|
|
|||||||
|
|||||||
